Comparison between Anthem Biosciences IPO and Laxmi India Finance IPO.
Anthem Biosciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Laxmi India Finance IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anthem Biosciences IPO is up to ₹3,395.00 Cr whereas the issue size of the Laxmi India Finance IPO is up to ₹254.26 Cr. The final issue price of Anthem Biosciences IPO is ₹570.00 per share and of Laxmi India Finance IPO is ₹158.00 per share.
| Anthem Biosciences IPO | Laxmi India Finance IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹5 per share |
| Issue Price (Lower) | ₹540.00 per share | ₹150.00 per share |
| Issue Price (Upper) | ₹570.00 per share | ₹158.00 per share |
| Issue Price (Final) | ₹570.00 per share | ₹158.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹50.00 per share | |
| Market Lot Size | 26 shares | 94 shares |
| Fresh Issue Size | 0 shares | 1,04,53,575 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹165.17 Cr |
| OFS Issue Size | 5,95,75,319 shares | 56,38,620 shares |
| OFS Issue Size (Amount) | up to ₹3,395.00 Cr | up to ₹89.09 Cr |
| Issue Size Total | 5,95,75,319 shares | 1,60,92,195 shares |
| Issue Size Total (Amount) | up to ₹3,395.00 Cr | up to ₹254.26 Cr |
Anthem Biosciences IPO opens on Jul 14, 2025, while Laxmi India Finance IPO opens on Jul 29, 2025. The closing date of Anthem Biosciences IPO and Laxmi India Finance IPO is Jul 16, 2025, and Jul 31, 2025, respectively.
| Anthem Biosciences IPO | Laxmi India Finance IPO | |
|---|---|---|
| Anchor Bid Date | Jul 11, 2025 | Jul 28, 2025 |
| Issue Open | Jul 14, 2025 | Jul 29, 2025 |
| Issue Close | Jul 16, 2025 | Jul 31, 2025 |
| Basis Of Allotment (Tentative) | Jul 17, 2025 | Aug 01, 2025 |
| Initiation of Refunds (Tentative) | Jul 18, 2025 | Aug 04, 2025 |
| Credit of Share (Tentative) | Jul 18, 2025 | Aug 04, 2025 |
| Listing date (Tentative) | Jul 21, 2025 | Aug 05, 2025 |
| Anchor Lockin End date 1 | Aug 15, 2025 | Aug 30, 2025 |
| Anchor Lockin End date 2 | Oct 14, 2025 | Oct 29, 2025 |
Anthem Biosciences IPO P/E ratio is 70.62, as compared to Laxmi India Finance IPO P/E ratio of 18.35.
| Anthem Biosciences IPO | Laxmi India Finance IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anthem Biosciences Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 23% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Laxmi India Finance Ltd.'s revenue increased by 42% and profit after tax (PAT) rose by 60% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 76.87 | 89.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.68 | 60.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 70.62 | 18.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹31867.39 Cr. | ₹825.83 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.82% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.88% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.05 | 4.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.07 | ₹8.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.82% | 13.95% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anthem Biosciences IPO Retail Individual Investors (RII) are offered 2,07,95,834 shares while in Laxmi India Finance IPO retail investors are offered 2,07,95,834 shares. Qualified Institutional Buyers (QIB) are offered 1,18,83,333 shares in Anthem Biosciences IPO and 31,86,253 shares in Laxmi India Finance IPO.
| Anthem Biosciences IPO | Laxmi India Finance IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,78,24,999 shares | 47,79,379 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 1,18,83,333 shares | 31,86,253 shares |
| NII | 89,12,500 shares | 23,89,691 shares |
| RII | 2,07,95,834 shares | 55,75,944 shares |
| Employee | 1,58,653 shares | 1,60,928 shares |
| Others | ||
| Total | 5,95,75,319 shares | 1,60,92,195 shares |
Anthem Biosciences IPO subscribed 67.42x in total, whereas Laxmi India Finance IPO subscribed 1.86x.
| Anthem Biosciences IPO | Laxmi India Finance IPO | |
|---|---|---|
| QIB (times) | 192.80x | 1.30x |
| NII (times) | 44.70x | 1.83x |
| Big NII (times) | 51.66x | 1.82x |
| Small NII (times) | 30.80x | 1.87x |
| RII (times) | 5.98x | 2.20x |
| Employee (times) | 6.99x | 1.54x |
| Other (times) | ||
| Total (times) | 67.42x | 1.86x |
